Rinvoq (Upadacitinib) Pills
Rinvoq (generic name: upadacitinib) is a prescription medication that belongs to a class of drugs known as Janus kinase (JAK) inhibitors.
How Rinvoq Works
Rinvoq works by inhibiting Janus kinase enzymes, which play a key role in the immune system’s inflammatory response. By blocking these enzymes, the medication helps reduce inflammation, pain, and joint damage in autoimmune diseases. Unlike traditional immunosuppressants, JAK inhibitors provide targeted relief, making them a valuable treatment option for patients who do not respond well to conventional therapies.
Conditions Treated by Rinvoq
Rinvoq is approved for the treatment of several autoimmune disorders, including:
- Rheumatoid Arthritis (RA) – Reduces joint pain, swelling, and stiffness.
- Psoriatic Arthritis (PsA) – Helps manage joint inflammation and skin symptoms.
- Atopic Dermatitis (Eczema) – Alleviates severe itching and skin inflammation.
- Ulcerative Colitis (UC) – Improves symptoms such as diarrhea and rectal bleeding.
- Crohn’s Disease – Helps manage abdominal pain and bowel irregularities.
Dosage and Administration
Rinvoq is available in tablet form and is typically taken once daily, with or without food. The dosage may vary depending on the condition being treated. It is important to follow a healthcare provider’s instructions carefully and not to exceed the prescribed dose.
Potential Side Effects
Like any medication, Rinvoq can cause side effects. Common ones include:
- Headache
- Nausea
- Upper respiratory infections
- Increased cholesterol levels